Search research articles
Contact Us
Filters
Showing results (231-240 of 247) with videos related to
Page
of 25
Sort By:
Molecular & Cellular Proteomics : MCP
|
June 3, 2019
Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma
Bracha Shraibman, Eilon Barnea, Dganit Melamed Kadosh, et al.
Frontiers in Immunology
|
December 21, 2023
Novel Spike-stabilized trimers with improved production protect K18-hACE2 mice and golden Syrian hamsters from the highly pathogenic SARS-CoV-2 Beta variant
Carlos Ávila-Nieto, Júlia Vergara-Alert, Pep Amengual-Rigo, et al.
Molecular & Cellular Proteomics : MCP
|
August 4, 2018
Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma
Bracha Shraibman, Eilon Barnea, Dganit Melamed Kadosh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 14, 2023
Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101)
Roberto Carmagnani Pestana, Justin T Moyers, Jason Roszik, et al.
Journal for Immunotherapy of Cancer
|
March 20, 2020
Phase 2 study of pembrolizumab in patients with advanced rare cancers
Aung Naing, Funda Meric-Bernstam, Bettzy Stephen, et al.
Cancer Discovery
|
September 16, 2024
AMG 193, a Clinical Stage MTA-Cooperative PRMT5 Inhibitor, Drives Antitumor Activity Preclinically and in Patients with MTAP-Deleted Cancers
Brian Belmontes, Katherine K Slemmons, Chun Su, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 30, 2025
Final Results from a First-in-Human Phase I Study of the Dual Isocitrate Dehydrogenase (IDH) 1/2 Inhibitor, LY3410738, in Advanced Solid Tumors Harboring IDH1 or IDH2 Mutations
James J Harding, Do-Youn Oh, Teresa Macarulla Mercade, et al.
Iscience
|
February 7, 2023
Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2
Antonio Barreiro, Antoni Prenafeta, Gregori Bech-Sabat, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 2, 2021
Plitidepsin has a positive therapeutic index in adult patients with COVID-19 requiring hospitalization
José F Varona, Pedro Landete, Jose A Lopez-Martin, et al.
Nature
|
February 14, 2019
Author Correction: HER kinase inhibition in patients with HER2- and HER3-mutant cancers
David M Hyman, Sarina A Piha-Paul, Helen Won, et al.
Page
of 25
Search research articles
Search
Showing results (231-240 of 247) with videos related to
Sort By:
Page
of 25
Molecular & Cellular Proteomics : MCP
|
June 3, 2019
Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma
Bracha Shraibman, Eilon Barnea, Dganit Melamed Kadosh, et al.
Frontiers in Immunology
|
December 21, 2023
Novel Spike-stabilized trimers with improved production protect K18-hACE2 mice and golden Syrian hamsters from the highly pathogenic SARS-CoV-2 Beta variant
Carlos Ávila-Nieto, Júlia Vergara-Alert, Pep Amengual-Rigo, et al.
Molecular & Cellular Proteomics : MCP
|
August 4, 2018
Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma
Bracha Shraibman, Eilon Barnea, Dganit Melamed Kadosh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 14, 2023
Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101)
Roberto Carmagnani Pestana, Justin T Moyers, Jason Roszik, et al.
Journal for Immunotherapy of Cancer
|
March 20, 2020
Phase 2 study of pembrolizumab in patients with advanced rare cancers
Aung Naing, Funda Meric-Bernstam, Bettzy Stephen, et al.
Cancer Discovery
|
September 16, 2024
AMG 193, a Clinical Stage MTA-Cooperative PRMT5 Inhibitor, Drives Antitumor Activity Preclinically and in Patients with MTAP-Deleted Cancers
Brian Belmontes, Katherine K Slemmons, Chun Su, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 30, 2025
Final Results from a First-in-Human Phase I Study of the Dual Isocitrate Dehydrogenase (IDH) 1/2 Inhibitor, LY3410738, in Advanced Solid Tumors Harboring IDH1 or IDH2 Mutations
James J Harding, Do-Youn Oh, Teresa Macarulla Mercade, et al.
Iscience
|
February 7, 2023
Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2
Antonio Barreiro, Antoni Prenafeta, Gregori Bech-Sabat, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 2, 2021
Plitidepsin has a positive therapeutic index in adult patients with COVID-19 requiring hospitalization
José F Varona, Pedro Landete, Jose A Lopez-Martin, et al.
Nature
|
February 14, 2019
Author Correction: HER kinase inhibition in patients with HER2- and HER3-mutant cancers
David M Hyman, Sarina A Piha-Paul, Helen Won, et al.
Page
of 25